Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Nature
|
November 28, 2019
An acute immune response underlies the benefit of cardiac stem cell therapy
Ronald J Vagnozzi, Marjorie Maillet, Michelle A Sargent, et al.
Nature Genetics
|
August 8, 2017
TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
Ken J Kron, Alexander Murison, Stanley Zhou, et al.
Molecular Carcinogenesis
|
October 17, 2015
Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model
Wenjuan Li, Chunjing Zhang, Hongyan Du, et al.
Journal of Pathology Informatics
|
November 10, 2025
Deep learning for digital pathology: A critical overview of methodological framework
Meghdad Sabouri Rad, Junze Vincent Huang, Mohammad Mehdi Hosseini, et al.
European Urology
|
January 28, 2019
Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer
Kathleen E Houlahan, Amirali Salmasi, Taylor Y Sadun, et al.
Oncotarget
|
December 1, 2016
Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer
Alireza Fotouhi Ghiam, Samira Taeb, Xiaoyong Huang, et al.
Scientific Reports
|
August 9, 2016
Simplified three-dimensional tissue clearing and incorporation of colorimetric phenotyping
Kevin Sung, Yichen Ding, Jianguo Ma, et al.
World Neurosurgery
|
May 20, 2020
Telemedicine in the Era of Coronavirus Disease 2019 (COVID-19): A Neurosurgical Perspective
Rachel Blue, Andrew I Yang, Cecilia Zhou, et al.
BMC Cancer
|
January 4, 2018
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
René Böttcher, Charlotte F Kweldam, Julie Livingstone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2019
On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation
Benjamin P Brown, Yun-Kai Zhang, David Westover, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Nature
|
November 28, 2019
An acute immune response underlies the benefit of cardiac stem cell therapy
Ronald J Vagnozzi, Marjorie Maillet, Michelle A Sargent, et al.
Nature Genetics
|
August 8, 2017
TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer
Ken J Kron, Alexander Murison, Stanley Zhou, et al.
Molecular Carcinogenesis
|
October 17, 2015
Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model
Wenjuan Li, Chunjing Zhang, Hongyan Du, et al.
Journal of Pathology Informatics
|
November 10, 2025
Deep learning for digital pathology: A critical overview of methodological framework
Meghdad Sabouri Rad, Junze Vincent Huang, Mohammad Mehdi Hosseini, et al.
European Urology
|
January 28, 2019
Molecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer
Kathleen E Houlahan, Amirali Salmasi, Taylor Y Sadun, et al.
Oncotarget
|
December 1, 2016
Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer
Alireza Fotouhi Ghiam, Samira Taeb, Xiaoyong Huang, et al.
Scientific Reports
|
August 9, 2016
Simplified three-dimensional tissue clearing and incorporation of colorimetric phenotyping
Kevin Sung, Yichen Ding, Jianguo Ma, et al.
World Neurosurgery
|
May 20, 2020
Telemedicine in the Era of Coronavirus Disease 2019 (COVID-19): A Neurosurgical Perspective
Rachel Blue, Andrew I Yang, Cecilia Zhou, et al.
BMC Cancer
|
January 4, 2018
Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations
René Böttcher, Charlotte F Kweldam, Julie Livingstone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2019
On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation
Benjamin P Brown, Yun-Kai Zhang, David Westover, et al.
Page
of 7